Prelude Capital Management’s Stoke Therapeutics STOK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-29,528	Closed	-$326K	–	1380
2024 Q4	$326K	Sell	29,528 -20,372	-41%	-$225K	0.02%	662
2024 Q3	$613K	Buy	+49,900	New	+$613K	0.04%	474